LABOTEC AWARDED THERMO FISHER SCIENTIFIC BIOPRODUCTION AGENCY FOR Southern Africa

Labotec is proud to announce a partnership with world leaders Thermo Fisher Scientific as trusted distributors of their Bioproduction portfolio for Southern Africa. Labotec and ThermoFisher Scientific are able to provide an open-architecture solution through single-use (SU) bioproduction technologies and consumables for research and development for biotherapeutic producers in pharmaceutical products such as vaccines, monoclonal antibodies (mAbs), adjuvants, personalised medicine, and others.

Synergies for Success Through Thermo Fisher Scientific’s worldwide manufacturing network, which is present in more than 100 countries on six continents and equipped with state-of-theart ISO 9001:2015 certified facilities that meet rigorous quality standards, combined with Labotec’s decades of experience in this field locally, the alliance is resolute in supporting the local market’s need for high-quality products, a stable supply chain and robust risk mitigation strategies for both up- and down-scale processes.

Bioprocessing by Design Bioprocessing by design is emphasised by Thermo Fisher Scientific to drive performance through collaboration with clients to deliver optimal customised solutions by integrating existing resources, understanding challenges, improving upor down-scaling processes, and enhancing speed and quality. At the same time, the biotherapeutic market is rapidly adopting single-use bioprocessing technologies due to efficiency in mitigating and reducing risk to improve operational efficiencies. This robust and scalable architecture from lab/ scale-up to cGMP production uses several single-use products; such as bioreactors, tangential-flow filtration devices, depth filters, disposable filter cartridges, bioprocess containers, and mixing systems for upstream as well as downstream processing. Factors that boost the growth of single-use bioprocessing in today’s market include increase in demand for biopharmaceuticals, validation pressures, rise in adoption of disposable technologies, low risk of product crosscontamination attributed to SUB technologies, and less floor space requirement.

Vaccine development for SARS-CoV-2 Even before the current global pandemic, Thermo Fisher Scientific has been at the forefront in vaccine development through their single-use bioproduction technologies and the associated bioprocessing consumables. With vaccine development now in the spotlight of scientific and medical research, Labotec and Thermo Fisher Scientific can provide an openarchitecture solution to those in vaccine research and development.

LABOTEC (PTY) LTD

JHB: (011) 315 5434 CPT: (021) 531 7660 DBN: (031) 566 4870 Fax: (011) 315 5882 sales@labotec.co.za www.labotec.co.za